ClinicalTrials.gg
Not yet recruitingNCT06519643Updated Jul 25, 2024

Building Your Successful Nursing Career

An interventional study of career planning application in Nurse's Role, Gender and Professional Burnout, sponsored by Chang Gung Memorial Hospital. Not yet recruiting. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Sex
Male
01

Study summary

This study aims to evaluate a career planning mobile App specifically tailored for male nurses.This three-year experimental project aims to recruit 120 male nurses (60)in the experimental group and 60 in the control group). Employing a prospective double-blind randomized controlled trial (RCT) design, the study will include six follow-up points (pre-intervention, post-intervention at 0, 6, 12, 18, and 24 months) to examine the effectiveness of career self-efficacy, career adaptive behaviors, occupational resilience, career success, and career continuity intentions of male nurses over time. The repeated measures data will be analyzed with the intention-to-treat analysis method and General Estimating Equations (GEE). This research represents an innovative development of the world's first theoretically grounded career planning mobile App for male nurses.The study's results can serve as a valuable reference for future career planning initiatives in nursing practice and education.

Read the detailed description

This study is a longitudinal study that adopts a double-blind randomized controlled trial (RCT). The study will recruit 120 male nurses and allocate them into the intervention group and the control group in a 1:1 ratio (60 in each group). Based on Super's (1957) career development theory and the four-stage career classification, the participating male nurses will be divided into the exploration stage (experience ≤ 2 years), establishment stage (experience 2-5 years), and maintenance stage (experience 5-15 years), with career stage as a confounding factor. The study uses 1:1:1 stratified randomization to ensure that the number of cases in the experimental group (n=60, exploration stage: establishment stage: maintenance stage = 20:20:20) and the control group (n=60) is the same, as well as the homogeneity of the career stage variables of the two groups. All included subjects will undergo an online pre-test (T0) before allocation, and then enter the experimental group or the control group according to the random assignment results. Both groups will be invited to use the "Building Your Successful Nursing Career" App for six months, with the experimental group receiving the full career planning mobile application intervention and two online Career Mentoring Programs, while the control group receives a sham treatment. Both groups will undergo five follow-up online data collections (0, 6, 12, 18, and 24 month post-intervention). The effectiveness of the career planning mobile application intervention on male nurses' career self-efficacy, career adaptive behaviors, occupational resilience, career success, and career continuity intentions will be examined using the intention-to-treat analysis method and General Estimating Equations (GEE).

02

Conditions studied

  • Nurse's Role
  • Gender
  • Professional Burnout

Keywords

  • male nurse
  • career plan
  • mobile application (App)
  • intervention study
  • randomized controlled trial
03

In context

Burnout, Professional

218 studies on the registry are indexed under Burnout, Professional; 35 are open to participants now.

This study's planned enrollment of 120 is above the median of 80 across 162 interventional studies indexed under Burnout, Professional.

Browse Burnout, Professional studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,098 studies on the registry; 241 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male nursing staff currently engaged in clinical nursing work.
  2. Care Within 15 years of working experience.
  3. Have a mobile phone with Internet access.
  4. Have clear consciousness and can understand and answer the researcher's questions.
  5. Audible and understandable Or understand Chinese.
  6. Willing to participate in this study and sign the subject consent form.

Exclusion criteria

Exclusion Criteria:

  1. Unwilling to participate in this study.
  2. Those who cannot download the App.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    the effectiveness of a career planning mobile application for male nurses

    This study aims to evaluate a career planning mobile app specifically tailored for male nurses. The investigators will compare the pre- and post-test differences between the experimental group and the control group. The experimental group will receive the full career planning mobile application intervention, while the control group will receive a sham treatment.

    Behavioral: career planning application

  • Sham comparator
    control

    This study aims to evaluate a career planning mobile app specifically tailored for male nurses. The investigators will compare the pre- and post-test differences between the experimental group and the control group. The experimental group will receive the full career planning mobile application intervention, while the control group will receive a sham treatment.

    Behavioral: career planning application

Interventions

  • Behavioralcareer planning application

    Arm 1 \[Experimental group\]: The experimental group will be assigned to participate in a career planning application named "Building Your Successful Nursing Career" App for six months. They will receive the full career planning mobile application intervention along with two online career mentoring sessions. Arm 2 \[Control group\]: The control group will also be assigned to participate in a career planning application named "Building Your Successful Nursing Career" App for six months. However, the control group will only receive a sham treatment. They will only access a few interfaces of the app.

06

What researchers measure

Primary outcomes

  1. career self-efficacy

    career self-efficacy will be collected by online structure questionnaire

    Time frame: before intervention and 0, 6, 12, 18, and 24 months post-intervention

  2. career adaptive behaviors

    career adaptive behavior will be collected by online structure questionnaire

    Time frame: before intervention and 0, 6, 12, 18, and 24 months post-intervention

  3. occupational resilience

    occupational resilience will be collected by online structure questionnaire

    Time frame: before intervention and 0, 6, 12, 18, and 24 months post-intervention

  4. career success

    career success will be collected by online structure questionnaire

    Time frame: before intervention and 0, 6, 12, 18, and 24 months post-intervention

  5. career continuity intentions

    career continuity intentions will be collected by online structure questionnaire

    Time frame: before intervention and 0, 6, 12, 18, and 24 months post-intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2024; primary completion for Aug 2027, 36 months later.

Of 128 non-industry interventional studies with no phase under Burnout, Professional, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's planned 36 months is above that.

Counting every sponsor, half of 132 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2024
First posted
Jul 25, 2024
StartEst.
Aug 1, 2024
Primary completionEst.
Aug 1, 2027
CompletionEst.
Aug 5, 2027
Last update
Jul 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06519643
Collaborators
Chang Gung University
Responsible party
Hsing-Yi Yu (Assistant Professor, Chang Gung Memorial Hospital) — Principal investigator
First posted
Jul 25, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 5, 2027 (estimated)
Last update
Jul 25, 2024

Study contacts

Yu Hsing-Yi, PhD
Contact
kanano@gmail.com
886-3-2118800 ext. 5064
Chao Yi-Ping, PhD
study director · Chang Gung University
Chiang Yueh-Tao, PhD
study director · Chang Gung University
DAI HUNG -DA, PhD
study director · Taipei Veterans General Hospital, Taiwan
Shen Yung-Chao, M.S.
study director · New Taipei Municipal Tu-Cheng Hospital
Lou Jiunn-Horng, PhD
study director · Hsin Sheng College of Medical Care and Management

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion